Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

multiClust: An R-package for Identifying Biologically Relevant Clusters in Cancer Transcriptome Profiles.

Lawlor N, Fabbri A, Guan P, George J, Karuturi RK.

Cancer Inform. 2016 Jun 12;15:103-14. doi: 10.4137/CIN.S38000. eCollection 2016. Review.

2.

Breast cancer subtype predictors revisited: from consensus to concordance?

Mj Sontrop H, Jt Reinders M, D Moerland P.

BMC Med Genomics. 2016 Jun 3;9(1):26. doi: 10.1186/s12920-016-0185-6.

3.

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis.

Xu H, Tian Y, Yuan X, Liu Y, Wu H, Liu Q, Wu GS, Wu K.

Onco Targets Ther. 2016 Jan 21;9:431-44. doi: 10.2147/OTT.S97192. eCollection 2016.

4.

TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.

Chen C, Zhao KN, Masci PP, Lakhani SR, Antonsson A, Simpson PT, Vitetta L.

BMC Cancer. 2015 Dec 24;15:1010. doi: 10.1186/s12885-015-1993-3.

5.

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.

Cai H, Li X, Li J, Ao L, Yan H, Tong M, Guan Q, Li M, Guo Z.

Oncotarget. 2015 Dec 29;6(42):44593-608. doi: 10.18632/oncotarget.6260.

6.

Highly informative marker sets consisting of genes with low individual degree of differential expression.

Galatenko VV, Shkurnikov MY, Samatov TR, Galatenko AV, Mityakina IA, Kaprin AD, Schumacher U, Tonevitsky AG.

Sci Rep. 2015 Oct 8;5:14967. doi: 10.1038/srep14967.

7.
8.

Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells.

Hsu PY, Hsu HK, Hsiao TH, Ye Z, Wang E, Profit AL, Jatoi I, Chen Y, Kirma NB, Jin VX, Sharp ZD, Huang TH.

Oncogene. 2016 May 5;35(18):2379-89. doi: 10.1038/onc.2015.298. Epub 2015 Aug 24.

9.

Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatment.

Li B, Li Y, Wang XY, Yan ZQ, Liu H, Liu GR, Liu SL.

Am J Cancer Res. 2015 Jan 15;5(2):726-37. eCollection 2015.

10.

Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas.

Wong P, Hui A, Su J, Yue S, Haibe-Kains B, Gokgoz N, Xu W, Bruce J, Williams J, Catton C, Wunder JS, Andrulis IL, Gladdy R, Dickson B, O'Sullivan B, Liu FF.

Oncotarget. 2015 Nov 17;6(36):39127-39. doi: 10.18632/oncotarget.3926.

11.

Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design.

Slade DJ, Fang P, Dreyton CJ, Zhang Y, Fuhrmann J, Rempel D, Bax BD, Coonrod SA, Lewis HD, Guo M, Gross ML, Thompson PR.

ACS Chem Biol. 2015 Apr 17;10(4):1043-53. doi: 10.1021/cb500933j. Epub 2015 Jan 26.

12.

Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer.

Hallett RM, Hassell JA.

BMC Cancer. 2014 Nov 24;14:871. doi: 10.1186/1471-2407-14-871.

13.

NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer.

Hu R, Warri A, Jin L, Zwart A, Riggins RB, Fang HB, Clarke R.

Mol Cell Biol. 2015 Jan;35(2):379-90. doi: 10.1128/MCB.00847-14. Epub 2014 Nov 3.

14.

Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.

Andruska N, Zheng X, Yang X, Helferich WG, Shapiro DJ.

Oncogene. 2015 Jul;34(29):3760-9. doi: 10.1038/onc.2014.292. Epub 2014 Sep 29.

15.

Más-o-menos: a simple sign averaging method for discrimination in genomic data analysis.

Zhao SD, Parmigiani G, Huttenhower C, Waldron L.

Bioinformatics. 2014 Nov 1;30(21):3062-9. doi: 10.1093/bioinformatics/btu488. Epub 2014 Jul 23.

16.

Cross-study validation for the assessment of prediction algorithms.

Bernau C, Riester M, Boulesteix AL, Parmigiani G, Huttenhower C, Waldron L, Trippa L.

Bioinformatics. 2014 Jun 15;30(12):i105-12. doi: 10.1093/bioinformatics/btu279.

17.

An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer.

Mannelqvist M, Wik E, Stefansson IM, Akslen LA.

PLoS One. 2014 Jun 6;9(6):e98787. doi: 10.1371/journal.pone.0098787. eCollection 2014.

18.

Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences.

Fox NS, Starmans MH, Haider S, Lambin P, Boutros PC.

BMC Bioinformatics. 2014 Jun 6;15:170. doi: 10.1186/1471-2105-15-170.

19.

Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.

Sinn P, Aulmann S, Wirtz R, Schott S, Marmé F, Varga Z, Lebeau A, Kreipe H, Schneeweiss A.

Geburtshilfe Frauenheilkd. 2013 Sep;73(9):932-940.

20.

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer.

Al-Ejeh F, Simpson PT, Sanus JM, Klein K, Kalimutho M, Shi W, Miranda M, Kutasovic J, Raghavendra A, Madore J, Reid L, Krause L, Chenevix-Trench G, Lakhani SR, Khanna KK.

Oncogenesis. 2014 Apr 21;3:e100. doi: 10.1038/oncsis.2014.14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk